Plexus (PLXS) Expected to Announce Earnings on Wednesday

Plexus (NASDAQ:PLXS) is anticipated to issue its quarterly earnings data before the market opens on Wednesday, January 22nd. Analysts expect the company to announce earnings of $1.59 per share and revenue of $982,320.00 billion for the quarter. Plexus has set its Q1 guidance at $1.52-$1.67 EPS and its Q1 2025 guidance at 1.520-1.670 EPS.Persons interested in listening to the company’s earnings conference call can do so using this link.

Plexus (NASDAQ:PLXS) last issued its quarterly earnings results on Wednesday, October 23rd. The technology company reported $1.85 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.30. Plexus had a net margin of 2.82% and a return on equity of 9.51%. The business had revenue of $1.05 billion for the quarter, compared to the consensus estimate of $1.01 billion. During the same quarter in the previous year, the firm earned $1.44 earnings per share. The company’s revenue for the quarter was up 2.6% on a year-over-year basis. On average, analysts expect Plexus to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Plexus Trading Up 1.5 %

Shares of PLXS stock opened at $167.36 on Monday. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.71 and a current ratio of 1.51. Plexus has a 52-week low of $90.18 and a 52-week high of $170.07. The stock has a fifty day simple moving average of $161.73 and a two-hundred day simple moving average of $140.12. The firm has a market capitalization of $4.53 billion, a PE ratio of 41.74 and a beta of 0.91.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on PLXS. KeyCorp started coverage on shares of Plexus in a research report on Tuesday, October 22nd. They set a “sector weight” rating on the stock. Needham & Company LLC increased their price target on Plexus from $144.00 to $162.00 and gave the company a “buy” rating in a report on Friday, October 25th. StockNews.com upgraded Plexus from a “hold” rating to a “buy” rating in a research report on Monday, November 18th. Stifel Nicolaus upped their price target on shares of Plexus from $136.00 to $150.00 and gave the stock a “hold” rating in a report on Tuesday, December 10th. Finally, Benchmark lifted their target price on Plexus from $150.00 to $165.00 and gave the company a “buy” rating in a research report on Monday, October 28th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Plexus presently has a consensus rating of “Moderate Buy” and an average target price of $159.00.

Insider Buying and Selling at Plexus

In other news, CAO Angelo Michael Ninivaggi, Jr. sold 3,113 shares of the firm’s stock in a transaction dated Tuesday, October 29th. The stock was sold at an average price of $144.19, for a total value of $448,863.47. Following the completion of the transaction, the chief accounting officer now directly owns 35,323 shares in the company, valued at $5,093,223.37. This trade represents a 8.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Patrick John Jermain sold 5,045 shares of Plexus stock in a transaction dated Monday, October 28th. The stock was sold at an average price of $143.13, for a total value of $722,090.85. Following the sale, the chief financial officer now directly owns 24,602 shares of the company’s stock, valued at $3,521,284.26. This trade represents a 17.02 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 34,091 shares of company stock worth $5,377,960 over the last three months. Corporate insiders own 1.76% of the company’s stock.

Plexus Company Profile

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.